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The failure of β-cells has a central role in the pathogenesis of type 2 diabetes, and the identification of novel approaches to improve functional β-cell mass is essential to prevent/revert the disease. Here we show a critical novel role for thrombospondin 1 (THBS1) in β-cell survival during lipotoxic stress in rat, mouse and human models. THBS1 acts from within the endoplasmic reticulum to activate PERK and NRF2 and induce a protective antioxidant defense response against palmitate. Prolonged palmitate exposure causes THBS1 degradation, oxidative stress, activation of JNK and upregulation of PUMA, culminating in β-cell death. These findings shed light on the mechanisms leading to β-cell failure during metabolic stress and point to THBS1 as an interesting therapeutic target to prevent oxidative stress in type 2 diabetes. The prevalence of diabetes has reached 415 million people worldwide and is projected to affect 642 million by 2040. 1 Western diets and sedentary lifestyle are major contributors to the increased prevalence of type 2 diabetes (T2D). 2 In nondiabetic individuals, insulin resistance is compensated for by increased insulin secretion. Hyperglycemia develops in individuals who lack this compensatory response. 3 Pancreatic β-cell dysfunction is thus central to the development and progression of T2D. In post-mortem studies, β-cell mass is decreased by 40% in T2D patients, probably secondary to increased β-cell apoptosis. 4, 5 Why β-cells progressively fail in T2D is not well understood. Prospective studies indicate that increased circulating levels of even-chain saturated free fatty acids (FFAs), of which palmitate is the most common in man, are associated with T2D risk. 6, 7 Palmitate affects functional β-cell mass and induces β-cell apoptosis. 8 Accumulating evidence suggests that endoplasmic reticulum (ER) and oxidative stress are important mediators of β-cell failure in T2D. [9] [10] [11] [12] ER stress develops when the protein load in the ER exceeds the capacity of the organelle to handle proper protein folding. In response, cells activate an adaptive response called the unfolded protein response (UPR) that is governed by the ER transmembrane proteins PKR-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6). PERK attenuates protein translation and promotes expression of transcription factors such as ATF4. Palmitate depletes ER Ca 2+ and induces pronounced PERK signaling, leading to the induction of the BH3-only BCL2 proteins PUMA and DP5 and consequently β-cell death. 13, 14 Oxidative stress may also contribute to β-cell demise in T2D. Exposure of islets to palmitate increases the generation of reactive oxygen species (ROS) as a consequence of partial uncoupling of oxidative phosphorylation. 9 Islets from T2D patients have elevated ROS levels. 15 Thrombospondins (THBS) are multimeric Ca 2+ -binding glycoproteins produced by a large variety of cells. The THBS family consists of five members, of which THBS1 is the best studied. These secreted proteins have a large interactome, and thereby affect a variety of processes, including angiogenesis, platelet aggregation, cell adhesion and migration, wound healing, inflammation and cancer. 16 The secreted form of THBS1 is a 450 kDa homotrimeric protein that binds to proteins in the extracellular matrix, such as fibronectin, proteoglycans and integrins.
17 THBS1 also binds two membrane receptors, CD47 and CD36. The former has a role in the maintenance of immune tolerance, 18 while the latter mediates the antiangiogenic effect of THBS1. 19 The vascular density is increased in a range of tissues in THBS1 knockout mice. 20 These animals have hypervascular and hyperplastic islets but they are glucose intolerant. 21, 22 THBS1 deficiency decreases β-cell glucose-stimulated insulin release, proinsulin biosynthesis and glucose oxidation. 21, 23 In these studies, it was suggested that islet endothelial cell-secreted THBS1 modulates β-cell function by activating transforming growth factor β-1 (TGFβ1).
Recently, an important role for intracellular THBS has been identified. In cardiomyocytes, THBS1 and THBS4 favor an adaptive UPR 24 by binding to the luminal domain of the ER stress transducer ATF6α and promoting ATF6α nuclear shuttling. THBS thereby upregulates protective chaperones, such as binding immunoglobulin protein (BiP) and protein disulfide isomerase (PDI), and hence improves cardiac ER function and capacity. 24 In our previous RNA-sequencing studies, we observed that human islets and autofluorescence-activated cell sorting (FACS)-purified primary rat β-cells abundantly express THBS1. 25, 26 We hypothesized that intracellular THBS1 promotes an adaptive UPR and exerts direct β-cell protective effects. Surprisingly, we observed that THBS1 has a different and crucial role in β-cells. It acts as a master regulator of a PERK-NRF2-mediated antioxidant defense response that protects β-cells from lipotoxicity.
Results
ER-resident THBS1 protects β-cells against palmitate. We first examined the role of THBS1 in β-cell survival under lipotoxic conditions using loss-and gain-of-function approaches. THBS1 knockdown by siRNA potentiated palmitate-induced mitochondrial cytochrome c release Figures S1C and D) . THBS1 is synthesized in the ER where it can reside or be secreted, depending on the cell type and Ca 2+ levels. 27 Most of the intracellular THBS1 co-localized with the ER marker PDI (Supplementary Figure S2A) . THBS1 was also detected in the Golgi apparatus but not in the mitochondria (Supplementary Figure S2A) . To examine whether secreted THBS1 protects the cells via membrane receptor activation, we used conditioned medium from THBS1-overexpressing INS-1E cells, containing the 450 kDa homotrimeric secreted form of THBS1 (Supplementary Figure S1E) . This medium, however, failed to prevent palmitate toxicity (Figure 1h ). Exogenously added purified human THBS1 induced early phosphorylation of P38 mitogen-activated protein kinase (P38; Supplementary  Figure S1F ), as previously shown in other cell types. 28 Similar to conditioned medium, however, exogenous THBS1 did not protect β-cells against lipotoxic death when added 24 h before and/or during palmitate exposure (Figure 1i ).
The role of intracellular THBS1 was further examined using a THBS1 adenovirus containing the ER retention sequence KDEL. The THBS1-KDEL construct induced THBS1 overexpression in the ER as indicated by the co-localization with PDI or SERCA2 (Supplementary Figure S2B) . THBS1-KDEL overexpressing cells were similarly protected against palmitate compared with cells overexpressing THBS1-FLAG (Figures 1j and k) . These results demonstrate that ER-resident THBS1 is important for β-cell survival in lipotoxic conditions.
Palmitate induces THBS1 degradation. Because lipotoxicity is modulated by THBS1 expression levels, we evaluated whether FFA exposure modifies THBS1 expression. THBS1 mRNA levels were not altered in human islets exposed to palmitate, the monounsaturated FFA oleate or the combination of both FFAs (Supplementary Figure S1G) . Palmitate reduced expression of endogenous and adenovirally induced THBS1 mRNA in dispersed human islet cells ( Supplementary  Figures S1B and D) , while it increased THBS1 mRNA levels in INS-1E cells (Supplementary Figure S1H) . At the protein level, THBS1 expression was decreased in INS-1E cells and human islets under lipotoxic conditions (Figures 2a and b and Supplementary Figure S2C ). Palmitate induces ER stress and consequently attenuates protein translation via PERKmediated eIF2α phosphorylation.
14 To test whether the reduction of THBS1 protein by palmitate might be caused by attenuated protein translation, we measured THBS1 stability after shutdown of protein translation. An 8 h cycloheximide exposure decreased THBS1 expression by 36% (Figure 2c ), compared with a reduction by 53% for palmitate (Figure 2a ). Salubrinal, a selective inhibitor of eIF2α dephosphorylation that potently inhibits β-cell protein synthesis, 29 did not alter THBS1 expression (Figure 2d ). We therefore examined whether THBS1 is actively degraded during palmitate exposure. Pharmacological proteasome inhibition by MG132 fully prevented lipotoxic THBS1 downregulation (Figure 2e ). Taken together, these results show that palmitate induces THBS1 degradation in the proteasome.
THBS1 modulates oxidative stress in β-cells. We next characterized the mechanisms of THBS1 cytoprotection. As THBS1 induces an adaptive UPR via activation of ATF6 in cardiomyocytes, 24 we examined the ER stress response in β-cells. THBS1 knockdown decreased palmitate-induced expression of genes in the PERK pathway, namely CHOP, ATF4 and ATF3 (Figure 3a) . Spliced X-box-binding protein 1 (XBP1s), but not IRE1 phosphorylation or expression, was also reduced by THBS1 silencing in palmitate-treated cells (Figure 3a and Supplementary Figure S3A) . ATF6 activation was assessed using an ATF6-GFP construct that upon palmitate exposure is cleaved to the active 77 kDa protein (corresponding to the 50 kDa native ATF6). ATF6 cleavage was decreased in THBS1-deficient cells under lipotoxic conditions (Supplementary Figure S3B) . However, this change in ATF6 processing did not alter ATF6 reporter activity (Figure 3c ) after palmitate exposure or affect expression of the ATF6 targets BiP or GRP94 (Figures 3a and b) . Similarly, islets from THBS1 knockout mice 21 have similar BiP expression compared with wild-type islets (Figure 3d ).
To further investigate whether THBS1 induces a protective β-cell UPR, we performed the mirror experiment using the THBS1 adenovirus. THBS1 overexpression did not alter palmitate-induced PERK or IRE1 signaling and it did not affect ATF6 activation or downstream targets (Figures 3e and f and Supplementary Figures S3C and D) . As THBS1-depleted cells showed reduced ATF6 cleavage in response to palmitate, we assessed whether THBS1-mediated protection is ATF6 dependent. Adenoviral THBS1-FLAG overexpression decreased palmitate toxicity similarly in ATF6-silenced or control β-cells (Supplementary Figures S3E and F) . These data suggest that, different from cardiomyocytes, THBS1 does not protect β-cells via promotion of an adaptive UPR.
To determine whether THBS1 has general antiapoptotic properties, we examined other cell death stimuli. THBS1 overexpression protected cells from H 2 O 2 but not from the BCL2/BCL-XL inhibitor ABT-737 or the general kinase inhibitor staurosporin ( Figure 4a ). These results suggest that THBS1 modulates oxidative stress, a pathway previously implicated in β-cell lipotoxicity. 9 To test this hypothesis, we measured ROS using 2',7'-dichlorodihydrofluorescein diacetate, which is converted in the fluorescent form 2',7'-dichlorofluorescein (DCF) upon intracellular oxidation. Palmitate increased the DCF signal by 3-fold; this was augmented by THBS1 knockdown and inhibited by THBS1 overexpression (Figure 4b ). Similar results were observed in dispersed human islets (Figure 4c ). The cytoplasmic antioxidant enzymes glutathione s-transferase mu 1 (GSTM1) and catalase were upregulated by palmitate (Figure 4d ), but this was abolished in THBS1-depleted cells (Figure 4d ). Conversely, THBS1 overexpression further upregulated GSTM1 and catalase expression in palmitate-treated cells (Figure 4e ). On the other hand, the mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2) was not modified by palmitate or THBS1 gain or loss of function (Figures 4d and e) , suggesting a cell compartmentspecific response. THBS1 also modulates oxidative stress in vivo, as GSTM1 was significantly decreased and catalase tended to be lower in THBS1
− / − mouse islets (Figure 4f ). To test whether oxidative stress mediates lipotoxic cell death in THBS1-deficient conditions, we used the O 2 − scavenger MnTMPyP. MnTMPyP partially protected rat islet cells from palmitate and abolished THBS1 silencing-mediated apoptosis (Figure 4g ). Collectively, these results show that THBS1 protects β-cells from lipotoxicity by coordinating an antioxidative stress response.
THBS1 induces a PERK-and NRF2-dependent antioxidative stress defense. Induction of oxidative or ER stress in β-cells leads to the activation of the transcription factors nuclear factor erythroid-2-related factor-2 (NRF2; ref. 30 ) and ATF4, 31 previously shown to regulate antioxidant enzymes. 32, 33 Palmitate transiently increased NRF2 protein expression (Supplementary Figure S4A) . NRF2 knockdown induced β-cell apoptosis in basal or palmitate condition (Supplementary Figures S4B and C) , whereas ATF4 silencing was cytoprotective (data not shown). Given the proapoptotic role of ATF4, we focused subsequent experiments on NRF2. Neither THBS1 siRNA nor THBS1 overexpression altered NRF2 expression (Figure 5a ). We next tested whether prosurvival signals from THBS1 are indeed NRF2-dependent. The cytoprotection from lipotoxicity conferred by THBS1 was lost in NRF2-depleted cells (Figures 5b and c) . NRF2 controls the expression of cellular antioxidant and detoxifying enzymes by binding to antioxidant response elements (ARE) in their promoter regions. 34 To assess the activation of NRF2 by THBS1, we used the pARE-TI-luciferase reporter. 35 Palmitate increased ARE reporter activity by 2-fold. This was abolished by THBS1 knockdown and enhanced in THBS1-overexpressing cells (Figures 5d and e) . Supporting the pivotal role of NRF2 in β-cell antioxidative stress defenses, silencing NRF2, but not ATF4, decreased palmitate-induced GSTM1 and catalase mRNA expression (Figures 5f and g ). In keeping with this, the potentiation of GSTM1 and catalase expression by THBS1 overexpression was abolished in NRF2-deficient cells, whereas it was preserved in ATF4-deficient cells (Figures 5f and g ).
NRF2 is kept inactive in the cytoplasm by interaction with Kelch ECH associating protein 1 (Keap1). During oxidative stress, Keap1 is modified by ROS and loses affinity for NRF2, allowing its nuclear translocation. 36 The NRF2-Keap1 interaction can be also altered by phosphorylation of NRF2. During ER stress, PERK phosphorylates NRF2, leading to its nuclear translocation and target gene activation. 37 Consistent with the decreased expression of downstream targets of PERK in THBS1-deficient cells (Figure 3a) , palmitate-induced PERK phosphorylation was reduced at early time points (3 and 6 h) by THBS1 knockdown (Figure 6a ). Conversely, THBS1 overexpression potentiated PERK phosphorylation after 3 or 6 h of palmitate exposure (Figure 6b ). To directly assess the role of PERK in the THBS1-NRF2 pathway, we used the PERK inhibitor GSK2606414. 38 PERK inhibition abolished ARE luciferase reporter activity in palmitate-treated THBS1-overexpressing cells (Figures 6c and d) suggesting that PERK activates NRF2 downstream of THBS1. In keeping with these findings, PERK inhibition decreased GSTM1 and catalase mRNA expression in THBS1-overexpressing cells (Figure 6e ). These data suggest that THBS1 promotes PERK activation, stimulates NRF2 activity and transcriptionally induces a prosurvival antioxidative response in β-cells. Loss of THBS1 expression causes β-cell death via the JNK-PUMA pathway. Palmitate induces THBS1 degradation (Figure 2 ), which potentiates lipotoxicity through oxidative stress. We next investigated the downstream signals that culminate in β-cell apoptosis. c-Jun N-terminal kinase (JNK) and P38 are activated by oxidative stress in β-cells. Palmitate-induced JNK and P38 phosphorylation was enhanced in THBS1-deficient cells (Figure 7a and Supplementary Figure S5A) , while THBS1 overexpression reduced both (Figure 7a and Supplementary Figure S5B) . Using chemical inhibition, we observed that JNK, but not P38, mediates apoptosis in palmitate-treated THBS1-deficient cells (Figures 7b and c) . Of the three known JNK isoforms, JNK1 has been shown to be proapoptotic in β-cells.
40 JNK1
knockdown protected cells from apoptosis secondary to THBS1 silencing (Supplementary Figures S5C and D) , confirming the results using chemical inhibition. Induction of cytochrome c release and activation of caspase-3 (present data) indicate that THBS1 deficiency leads to cell death via the mitochondrial pathway of apoptosis. We next evaluated the involvement of BCL2 family members in the apoptotic process. The antiapoptotic proteins BCL2 or BCL-XL were not modified by THBS1 silencing (Supplementary Figure S6A) , but the proapoptotic BH3-only BCL2 family members DP5 and PUMA were upregulated (Figure 7d and Supplementary Figure S6B ). In the mirror experiment, THBS1 overexpression attenuated PUMA expression (Figure 7e (Figures 7f and g ). We next double knocked down THBS1 and all proapoptotic BH3-only BCL2 family members known to contribute to lipotoxic β-cell death.
13,41,42 PUMA silencing fully protected against THBS1 depletion (Figure 7h ), whereas DP5, BIM or BAD knockdown were ineffective (Figure 7h ). These results demonstrate that loss of THBS1 expression induces JNK-PUMA-mediated β-cell death.
Discussion
We presently identified a novel function of the ER-resident protein THBS1 as an upstream activator of PERK-NRF2-dependent antioxidative and prosurvival signaling (Figure 8 ). Our data identify PERK as a new member of the intracellular THBS1 interactome. THBS1 favors PERK phosphorylation and consequently NRF2 activation, thereby equipping β-cells with an effective antioxidative stress defense against lipotoxicity. Prolonged palmitate exposure, however, eventually results in proteasomal THBS1 degradation, loss of antioxidant enzyme expression and β-cell oxidative stress. This leads to JNK activation and PUMA-dependent triggering of the mitochondrial pathway of apoptosis. THBS1 and THBS4 were previously shown to induce an adaptive UPR in the heart by interacting with ATF6, facilitating its ER-to-Golgi translocation and enhancing the ATF6 transcriptional program. 24 Both THBS1 and THBS4 bind to ATF6 via the type 3 repeat domain. 24 THBS1 is abundantly expressed in β-cells, but THBS4 is nearly absent (RPKMo0.05; evaluated by RNA sequencing). 26 In contrast with the findings in cardiac as well as skeletal myocytes, THBS1 does not promote ATF6 signaling in β-cells. Another interesting difference between β-cells and heart is the subcellular site of action of THBS1. Lynch et al. 24 showed that increased ATF6 activation in cardiomyocytes was dependent on THBS translocation to the Golgi, with ER-retained THBS being inactive. In β-cells, ER-resident THBS1 regulates PERK phosphorylation. This points to cell type-specific regulation of ER stress signaling. In keeping with this idea, palmitate induces ATF6 activation and BiP expression in cardiomyocytes, 43 whereas it does not induce BiP protein in β-cells. Our present findings identify intracellular THBS as a regulator of PERK. Whether THBS1 directly interacts with PERK in the ER and perhaps promotes its oligomerization remains to be examined. Our results show that THBS1 enhances early PERK phosphorylation and prosurvival PERK-NRF2 signaling in β-cells. The data are in keeping with the cardiac gene expression signature of mild PERK activation in THBS4 overexpressing mice. 24 PERK phosphorylates NRF2, leading to its nuclear import, maintenance of cellular redox homeostasis and prosurvival signaling. 37 Our current data identify palmitate-induced targeting of THBS1 for proteasomal degradation as a mechanism that terminates the early prosurvival signals of PERK. Indeed, prolonged activation of the PERK pathway under lipotoxic conditions is essentially proapoptotic. 13, 14, 29 By maintaining THBS1 levels in the ER using adenoviral overexpression, we improved β-cell survival under lipotoxic conditions. THBS1 promotes NRF2 activation and increases expression of the ROS scavenging enzymes GSTM1 and catalase. NRF2 is a master regulator of the oxidative stress response by modulating expression of ARE-containing genes, including enzymes involved in glutathione biosynthesis, H 2 O 2 scavengers and chemical detoxification. 45 At variance with the antioxidant response induced by intracellular THBS1, extracellular administration of THBS1 or agonist receptor peptides stimulate ROS production. 47 Islets from T2D patients have significantly higher PUMA mRNA levels. 47 The THBS1-dependent inhibition of PUMA makes THBS1 induction an attractive strategy to improve β-cell fate in T2D.
THBS1 is an important therapeutic target in the cancer field due to its potential to restrain angiogenesis and inhibit tumor growth.
These effects are essentially mediated extracellularly. 48 Extracellular THBS1 has been suggested to have a deleterious role in obesity and insulin resistance, and a recent report identified circulating THBS1 as a biomarker of pre-diabetes. 49 THBS1 is more abundantly expressed in visceral compared with subcutaneous fat, and it is increased by high fat feeding and obesity. 50 ,51 THBS1 − / − mice are protected from high-fat-diet-induced obesity and insulin resistance through increased skeletal muscle insulin sensitivity and browning of subcutaneous fat. 50 Because these mice have increased serum FFA and triglyceride levels, it was suggested that THBS1 in the adipose interstitial matrix facilitates CD36-mediated FFA uptake. 52 Intracellular THBS1 induction rather than extracellular upregulation should therefore be envisaged as a novel therapeutic target in metabolic disease.
In conclusion, we demonstrate that ER-resident THBS1 is an important prosurvival factor in β-cells facing lipotoxic conditions. By promoting PERK-dependent NRF2 activation and consequently upregulating oxidative stress defense enzymes, THBS1 protects β-cells against the deleterious effects of palmitate. This study identifies THBS1 as a protective regulator of ER stress and antioxidant responses in β-cells. The Materials and Methods INS-1E cells, FACS-purified primary rat β-cells, mouse islets and human islets. The rat insulin-producing INS-1E cell line (a kind gift from Professor C Wollheim, Centre Medical Universitaire, Geneva, Switzerland) was cultured in RPMI 1640 (with 2 mM GlutaMAX-I) containing 5% FBS 53 and used at passages 60-72.
Male Wistar rats (Charles River Laboratories, Brussels, Belgium) were used according to the Belgian Regulations for Animal Care. All the experiments were approved by the local Ethical Committee. Islets were separated by collagenase digestion, handpicked, dispersed in single cells and β-cells purified by FACS (FACSAria, BD Biosciences, San Jose, CA, USA), 40 with purity and viability 490%. Islets from 10-13-week-old THBS1 knockout 23 or wild-type mice were used for mRNA expression and cell death studies.
Human islets (from nine donors, age 62 ± 5 years, BMI 25 ± 3 kg/m 2 , six males and three females, cause of death cerebral hemorrhage (four), cardiovascular disease (three), trauma (one) or unknown (one)) were isolated by collagenase digestion and density gradient purification. The islets were cultured, dispersed and transfected as described. 54 The percentage of β-cells, examined by insulin immunofluorescence, 14 was 53 ± 7%.
Treatments. For FFA exposure, the INS-1E cells were cultured in medium with 1% FBS and 0.75% FFA-free BSA. 55 Palmitate and oleate (Sigma, Schnelldorf, Germany) were dissolved in 90% ethanol, and used at a final concentration of 0.5 mM. Primary rat islet cells were exposed in medium with 0.75% FFA-free BSA, and human islets in medium with 1% charcoal-absorbed BSA. Both the methods result in similar unbound FFA concentrations. 55 Cycloheximide, MG132, ABT-737 and staurosporin were dissolved in DMSO and used at the indicated concentrations (Sigma). Salubrinal (ChemBridge, San Diego, CA, USA) was diluted in DMSO and used at 75 μM. H 2 O 2 (Sigma) and MnTMPyP (Alexis Biochemicals, Lausen, Switzerland) were diluted in water. The PERK inhibitor GSK2606414 (a kind gift from William Zuercher, GlaxoSmithKline, Research Triangle Park, NC, USA), the P38 inhibitor SB203580 and the JNK inhibitor SP600125 (Sigma) were dissolved in DMSO. The compounds were added 2 h before palmitate exposure and maintained in the medium together with palmitate. Lyophilized THBS1 (purified from human platelets, Calbiochem, San Diego, CA, USA) was diluted in bidistilled water and used at 2 μg/ml.
RNAi. Proteins were knocked down using specific siRNAs. The siRNAs against DP5, PUMA, BIM, ATF4, BAD and JNK1 were previously validated. 13, 41, 56, 57 THBS1 (rat THBS1-1 RSS362499, THBS1-2 RSS362500; human THBS1 RSS362501) and NRF2 siRNAs (NRF2-1 RSS343557, NRF2-2 RSS343558) were from Life Technologies (Carlsbad, CA, USA). ATF6 siRNA (s156439) was from Ambion (Foster City, CA, USA). The negative control of 21 nucleotide duplex RNA (Qiagen, Hilden, Germany) does not affect β-cell function, gene expression or viability. 58 Lipid-RNA complexes were formed in 100 μl Optimem1 containing 1 μl Lipofectamine RNAiMAX (Life Technologies) and 150 nM siRNA and added to the cells at a final concentration of 30 nM siRNA. 59 The transfected cells were cultured for 2 days before treatment.
Assessment of β-cell apoptosis. Apoptotic cells were counted by fluorescence microscopy after staining with the DNA-binding dyes propidium iodide (5 μg/ml) and Hoechst 33342 (10 μg/ml). 29 Apoptosis was confirmed by western blot (see below) for caspase-3 cleavage and by cytochrome c release, as previously described. 44 Real-time PCR. Poly(A) + -RNA was isolated and reverse transcribed. The realtime PCR amplification was done using IQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) on an MyiQ2 instrument and the PCR product concentration calculated as copies/μl using a standard curve. Gene expression from rat samples was corrected for the reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). β-Actin was used as the reference gene for mouse or human samples. Primer sequences are described in Supplementary Table S1 . Gene expression values are shown as fold change of control, except in the mouse islet experiments.
Western blot. Western blots were performed using 20 μg whole-cell extract protein. 29 IRE1 phosphorylation was detected using Phos-tag-SDS gels. 41 Briefly, the cell lysates were run on SDS-PAGE with 10 μM Phos-tag reagent (Wako, Richmond, VA, USA) and 100 μM MnCl 2 . The gels were then washed for 30 min in transfer buffer containing 1 mM EDTA and proteins transferred to a nitrocellulose membrane. For THBS1 detection in conditioned medium, INS-1E cells were transfected with adenovirus (see below). After 48 h, the medium was centrifuged at 20 000 × g for 20 min and 6 ml supernatant concentrated to 200 μl using Amicon Ultra Centrifugal Filters (Millipore, Tullagreen, Ireland). Laemmli load buffer (5 × ) was added and the samples were boiled for 5 min. The primary antibodies were anti-p-eIF2α (Ser51), eIF2α, β-actin, BCL2, ATF4, GRP94, COX4, BIM, p-P38 (Thr180/Tyr182), BCL-XL, p-JNK (Thr183, Tyr185), JNK, JNK1, PERK, p-PERK (Thr980), IRE1, BiP, GFP and cleaved caspase-3 from Cell Signaling (Beverly, MA, USA), XBP1, ATF3, CHOP and NRF2 from Santa Cruz Biotechnology (Santa Cruz, CA, USA), FLAG M2 and α-tubulin from Sigma, cytochrome c from BD Biosciences, GAPDH from Trevigen (Gaithersburg, MD, USA) and THBS1 from Thermo Scientific (Rockford, IL, USA). Horseradish peroxidase-labeled donkey anti-rabbit or donkey anti-mouse (1:10 000, Jackson Immuno Research, Baltimore Pike, PA, USA) antibodies were used as secondary antibodies. Protein signal was visualized using chemiluminescence Supersignal (Pierce, Rockford, IL, USA) and quantified using Scion Image (Scion Corporation, Frederick, MD, USA).
Infection with recombinant adenoviruses. The cells were infected either with adLUC (a luciferase-expressing control virus), adTHBS1 (expressing mouse THBS1 protein 24 ), adTHBS1-FLAG (expressing mouse THBS1 protein fused to the FLAG peptide; Sirion Biotech, Planegg, Germany) or adTHBS1-KDEL (expressing mouse THBS1 protein fused to KDEL; Sirion) and used at a multiplicity of infection of 1. After 3 h of infection, the medium was changed and the cells were treated or collected 48 h after infection. DCF assay. Oxidative stress was measured using the fluorescent probe 2', 7'-dichlorofluorescein diacetate (DCF; Sigma) in INS-1E cells seeded in 96-well black plates. After treatment, the cells were loaded with 10 μM DCF for 30 min at 37°C and washed. DCF fluorescence was quantified in Victor 2 reader (PerkinElmer, Walluf, Germany). The cells were then lysed and total protein measured. The data are expressed as DCF fluorescence corrected by total protein.
Plasmids and promoter reporter assay. The ATF6-GFP plasmid 60 was from Addgene (32955) and the UPRE luciferase reporter construct was kindly provided by Professor Prywes (Columbia University, New York, NY, USA). The pARE-TI-luciferase reporter (kindly provided by Professor Fahl, University of WisconsinMadison, Madison, WI, USA) contains a single copy of the 41-base pair murine GSTYa ARE and a minimal TATA-Inr promoter. The INS-1E cells were transfected using Lipofectamine 2000 with 250 ng reporter construct and the pRL-CMV plasmid (50 ng, with Renilla used as internal control for transfection efficiency), and 48 h later treated. Luciferase activities of cell lysates were expressed as relative luciferase/ Renilla activity.
Immunofluorescence. The INS-1E cells were fixed with 4% formalin, permeabilized with 0.1% Triton, blocked in PBS with 3% goat serum and incubated overnight with antibodies against THBS1 (Thermo Scientific), PDI, HSP60, RCAS1 (Cell Signaling) or SERCA2 (Life Technologies). Following staining with Hoechst 33342 and secondary antibodies conjugated with Alexa fluor 568 or 488 (Life Technologies), the slides were analyzed by inverted fluorescence microscopy (Zeiss Axiovert 200, Oberkochen, Germany) at × 20 magnification and 20°C. Confocal microscopy was performed in a LSM780 NLO system fitted on an Observer Z1 inverted microscope equipped with an alpha Plan-Apochromat × 63/1.46 oil objective (Zeiss). The 488 nm excitation wavelength of the Argon/2 laser, a main dichroic HFT 488/543 and a band-pass emission filter (BP 500-550 nm) were used for selective detection of the green fluorochrome (Alexa 488). The 543 nm excitation wavelength of the HeNe1 laser, a main dichroic HFT 488/543 and a long-pass emission filter (BP 590-650 nm) were used for selective detection of the red fluorochrome (Alexa 568). A 405 nm blue diode, a main dichroic HFT 405 and a band-pass emission filter (BP 415-465 nm) were used for selective detection of the DNA stain (Hoechst 33342). Images (512 by 512 pixels, zoom factor 4, line average 4; scaling: x-y: 0.066 micron, z: 0.327 micron) were acquired sequentially for each fluorochrome as a z-stack across the thickness of the cell and stored as eight-bits proprietary *.czi files. Single plane images were displayed and analyzed using Figure 8 Schematic representation of the main findings of the study. Palmitateinduced PERK/NRF2 signaling protects from oxidative stress. This protective pathway is disrupted by loss of THBS1 expression, exacerbating oxidative stress and apoptosis. ER denotes endoplasmic reticulum THBS1 protects β-cells from lipotoxic oxidative stress DA Cunha et al
